Product
BG00012
2 clinical trials
2 indications
Indication
Multiple SclerosisIndication
HealthyClinical trial
Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple SclerosisStatus: Completed, Estimated PCD: 2006-03-31
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Pharmacokinetics of BG00012 Administered With and Without 325 mg Aspirin in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2011-03-18